Hangzhou Putai Biotechnology Co., Ltd., located in Xuxian Industrial Park, Xiaoshan, Hangzhou, is a new high-tech enterprise established in 2018. The company takes "using genetic engineering technology to accelerate the development of innovative pharmaceutical products" as its business mission, and "customer-centric, integrity as the cornerstone, quality as the fundamental" as its core values.

In 2011, the founding shareholder of Putai bio established health path Pharma Co., Ltd., a manufacturing enterprise in Cambodia, which is now one of the most important pharmaceutical companies in Cambodia. On the one hand, Putai biology is a pilot research and development base of health path Pharma in China, on the other hand, it will provide various gene recombination products and technical services for domestic and foreign counterparts.

At present, the products of Putai bio have been developed and put into production include: Recombinant trypsin, recombinant enterokinase, recombinant lysine endonuclease, recombinant carboxypeptidase B and other enzyme products; Recombinant GM-CSF, recombinant G-CSF, recombinant interferon and other cytokine products.

Putai biology has a complete R & D, production and quality management system. The company has more than tons of fermentation tanks and supporting separation, purification, verification and other equipment and facilities, which can meet the needs of industrial customers.

At present, Putai biology has carried out scientific research cooperation and personnel training with Zhejiang University, Zhejiang University of science and technology, Zhejiang University of science and technology and other universities, and is committed to building an excellent scientific research and development team, contributing to the development of biological pharmaceutical industry at home and abroad.